Lon Schneider, MD
Keck School of Medicine of USC, Los Angeles, CA · University of Southern California · University of Southern California Keck School of Medicine Memory and Aging Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Lon Schneider, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:14 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT05267535 · Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's DiseaseNeurim Pharmaceuticals Ltd. · terminated · Alzheimer's Disease · study chair
- Ph2NCT04838301 · Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's DiseaseUniversity of Arizona · active not recruiting · Alzheimer Dementia, Late Onset Alzheimer Disease, Neurodegenerative Diseases · principal investigator
- Ph2NCT02615002 · Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)Neurim Pharmaceuticals Ltd. · completed · Alzheimer's Disease · study chair
- Ph3NCT00898807 · Citalopram for Agitation in Alzheimer's DiseaseJHSPH Center for Clinical Trials · completed · Alzheimer's Disease, Agitation · principal investigator
- N/ANCT00015548 · CATIE-Alzheimer's Disease TrialNational Institute of Mental Health (NIMH) · completed · Alzheimer's Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical TrialR01AG063826 · NIA · UNIVERSITY OF ARIZONA · PI ROBERTA EILEEN BRINTON, KATHLEEN E. RODGERS, LON S SCHNEIDER · fiscal years 2019 to 2025Named on NCT04838301
- Citalopram Treatment for Agitation in Alzheimer DementiaR01AG031348 · NIA · JOHNS HOPKINS UNIVERSITY · PI CONSTANTINE G LYKETSOS · fiscal years 2008 to 2012Named on NCT00898807
- CLINICAL ANTIPSYCHOTIC TRIALS OF INTERVENTION EFFECTIVES-278990001N01MH090001 · NIMH · UNIVERSITY OF NORTH CAROLINA C · PI · fiscal years 1989 to 2003Named on NCT00015548
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.